Eucrates Biomedical Acquisition Corp. EUCR

$ 10.04 0.0%

Annual report 2022
added 04-13-2023

Eucrates Biomedical Acquisition Corp. Balance Sheet 2011-2024 | EUCR

Annual Balance Sheet Eucrates Biomedical Acquisition Corp.

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	65.1 K	38.5 K	-	-	-	-	-	-	-	-	-	-
Total Liabilities	3.95 M	5.8 M	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-3.72 M	-5.49 M	-	-	-	-	-	-	-	-	-	-
Total Assets	12.5 M	105 M	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	18.9 K	49.2 K	551 K	-	-	-	-	-	-	-	-	-
Book Value	8.54 M	99.3 M	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-3.72 M	-5.49 M	-9.31 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Eucrates Biomedical Acquisition Corp.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	3.93 M	4.11 M	4.55 M	5.8 M	6.27 M	7.46 M	8.23 M	10.3 M	10.3 M	10.3 M	10.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-3.73 M	-3.79 M	-4.16 M	-5.49 M	-5.74 M	-2.3 M	-2.93 M	-9.31 M	-9.31 M	-4.92 M	-4.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	106 M	105 M	105 M	105 M	105 M	106 M	106 M	106 M	106 M	106 M	106 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	60 K	105 K	159 K	49.2 K	206 K	383 K	443 K	551 K	551 K	551 K	551 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	102 M	101 M	101 M	99.3 M	99.1 M	98.1 M	97.5 M	95.5 M	95.5 M	95.5 M	95.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-3.73 M	-3.79 M	-4.16 M	-5.49 M	-5.74 M	-6.69 M	-7.32 M	-9.31 M	-9.31 M	5 M	5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency